Authors
Kevin W. Chamberlin, PharmD, FASCP
Latest:
Elranatamab-bcmm Approved for Adult Patients With Relapsed or Refractory Multiple MyelomaThe novel drug elranatamab-bcmm (Elrexfio) received accelerated FDA approval on August 14, 2023, for treating adults with relapsed or refractory multiple myeloma.
Rami Chammas, PharmD, MPBA
Latest:
The Effects of COVID-19 on Specialty Prescribing HabitsThe remote and virtual way of treating patients is becoming the new norm. Specialty providers have to adapt to provide the most streamlined solutions.
Akunna Ihemaguba, BPS, PharmD
Latest:
Thermometers: A ReviewPharmacists must be familiar with the different thermometers so they can ensure proper use by the consumer.
Kenny Walter
Latest:
Electrical Nerve Field Stimulation May Help IBS Symptoms in Pediatric PatientsIBS in pediatric patients has not been studied much, but new data reveals a possible treatment.
